Folic acid supplementation reduces danger of stroke in people on medication for high blood pressure, new data suggests.
The Chinese primary prevention trial, including almost 21,000 hypertensive adults with no previous history of stroke or myocardial infarction, shows that a combination of the ACE inhibitor enalapril and a folate supplement significantly reduces the risk of first stroke.

To continue reading this article, please Log In or Sign Up for access.

HCP resources

Legal

The information on this website is intended for Australian healthcare professionals and is not intended for the general public. Consumers needing healthcare advice should talk to their healthcare professional.